Anna Sarakapina
Overview
Explore the profile of Anna Sarakapina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
0
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malandris K, Korakas E, Sarakapina A, Kalopitas G, Iatridi F, Liakos A, et al.
Dig Dis Sci
. 2024 Dec;
70(2):814-824.
PMID: 39708259
Aim: Controlled attenuation parameter (CAP) enables the noninvasive diagnosis of liver steatosis. Magnetic resonance imaging proton density fat fraction (MRI-PDFF) is increasingly used over biopsy for the assessment of steatosis...
2.
Gavriilidis S, Andrianopoulou R, Ntenti C, Sarakapina A, Trakatelli C, Polyzos S, et al.
Endocrine
. 2024 Aug;
87(1):73-78.
PMID: 39179734
Purpose: The evaluation of the effect of dulaglutide on glycated hemoglobin (HbA1c) and non-invasive indices of hepatic steatosis among different genotypes of the PNPLA3 I148M (rs738409) and CETP Taq1B (rs708272)...
3.
Malandris K, Papandreou S, Vasilakou D, Kakotrichi P, Sarakapina A, Kalopitas G, et al.
J Gastroenterol Hepatol
. 2024 Apr;
39(7):1219-1229.
PMID: 38627972
Background And Aim: Several agents are under investigation for nonalcoholic fatty liver disease (NAFLD). We assessed the comparative efficacy of pharmacologic interventions for patients with NAFLD focusing on magnetic resonance...